Salute e Benessere

Clue Launches "Connect the Dots" Campaign for Mental Health Awareness Month…

Clue , the most trusted, data-driven period and reproductive health tracking app, today announced its "Connect the Dots" campaign for Mental Health Awareness Month. The campaign highlights the critical, yet often overlooked connection between menstrual cycles and mental health. Additionally, with 90% of Clue members agreeing that tracking with Clue helps them better understand their body patterns, the campaign will focus on how cycle tracking can better help people understand their…
Nasdaq GlobeNewswire
08/05/2025

Press release: Transparency Notification from Shareholders

Transparency Notification from ShareholdersGhent, Belgium – 8 May 2025 – Sequana Medical NV (Euronext Brussels: SEQUA)(the " Company " or " SequanaMedical "), a pioneer in the treatment of drug-resistant fluid overload in liver disease, heart failure and cancer, announces today that it received a transparency notification in relation to the entities listed below, notifying the number of voting rights attached to the shares mentioned next to their name in the table below…
Nasdaq GlobeNewswire
08/05/2025

Blue Light Blocking Glasses Market to Reach $2.9 billion in 2024 in short term…

Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/request-sample/A65843 Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/request-sample/A65843 Market Introduction Blue light blocking glasses are personalized eyewear designed to cater to individual preferences in style, fit, and functionality. Production involves advanced design software, 3D printing, or traditional manufacturing methods. Orders are placed online or...
PR Newswire
08/05/2025

Home Healthcare Market Poised to Reach $ 747.70 Billion by 2030 at CAGR 10.21% -…

Request a free sample copy or view report summary: Home Healthcare Market Request a free sample copy or view report summary:Home Healthcare Market The demand for home care services is expected to increase in the immediate future, owing to the ongoing COVID-19 pandemic. These services are safer and cost-effective alternatives to hospital services. External substitutes, including hospitals, informal care, and other healthcare establishments, pose a limited threat, mostly due to their high...
PR Newswire
08/05/2025

Genmab Announces Financial Results for the First Quarter of 2024

May 8, 2025 Copenhagen, Denmark;Interim Report for the First Quarter Ended March 31, 2025Highlights EPKINLY ®(epcoritamab) approved by the Japan Ministry of Health, Labour and Welfare (MHLW) for additional indication as a treatment for relapsed or refractory follicular lymphoma (FL)Rinatabart sesutecan (Rina-S ® ) continues to show encouraging antitumor activity in patients with advanced ovarian cancer in data presented at the 2025 Society of Gynecologic...
Nasdaq GlobeNewswire
08/05/2025

Microphysiological System Market Soars: USD 148M in 2024 to USD 1134M by 2031 at…

Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-20K15201/Global_Microphysiological_System_Market. Get Free Sample:https://reports.valuates.com/request/sample/QYRE-Auto-20K15201/Global_Microphysiological_System_Market . Major Factors Driving the Growth Microphysiological System Market: The Microphysiological System (MPS) market is gaining momentum as a transformative tool in biomedical research, offering more accurate and human-relevant models compared to...
PR Newswire
08/05/2025

Closed Systems Transfer Devices Market worth US$2.09 billion by 2030 with 7.0%…

Browse in-depth TOC on "Closed Systems Transfer Devices Market" Browse in-depth TOC on "Closed Systems Transfer Devices Market" 273 - Tables 65 - Figures 289 - Pages By Based on type,the closed system transfer devices market is categorized into membrane-to-membrane systems and needleless systems. In 2023, the membrane-to-membrane systems segment held the largest share, by type. The high share and fast growth of this segment are due to their ease of use and lower rate of...
PR Newswire
08/05/2025

Hospital Asset Management Market is expected to generate a revenue of USD 414.18…

The hospital asset management market is gaining momentum as healthcare facilities embrace digital transformation. With rising investments in RFID, IoT, and cloud-based solutions, hospitals are optimizing workflows, reducing theft, and improving patient outcomes. The hospital asset management market is gaining momentum as healthcare facilities embrace digital transformation. With rising investments in RFID, IoT, and cloud-based solutions, hospitals are optimizing workflows, reducing theft, and...
PR Newswire
08/05/2025

MedTech Companies Paxman and Dignitana Announce Merger to Create a Stronger…

Paxman and Dignitana will now combine, creating a stronger, unified company - Paxman AB. This exciting merger will bring improved collaborations and connections, sharing new perspectives and strengths, working together as one team to improve patient outcomes. Paxman and Dignitana will now combine, creating a stronger, unified company - Paxman AB. This exciting merger will bring improved collaborations and connections, sharing new perspectives and strengths, working together as one team to...
PR Newswire
08/05/2025

Al in Pathology Market worth $347.4 million by 2030 with 26.5% CAGR |…

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=86647266 Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=86647266 Browse in-depth TOC on 'Al in Pathology Market' 269 - Tables 47 - Figures 292 - Pages By Based on segment,in 2024, the drug discovery segment accounted for the largest share of the market. This segment is also expected to grow at the highest CAGR during the forecast period. The increasing...
PR Newswire
08/05/2025

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities…

ORION CORPORATIONSTOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS 8 May 2025 at 16:30 EEST Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) Orion Corporation has received a disclosure under Chapter 9, Section 5 of the Securities Market Act, according to which the total number of Orion shares owned directly, indirectly and through financial instruments by BlackRock, Inc. and its funds decreased on 7 May 2025 below...
Nasdaq GlobeNewswire
08/05/2025

Coloplast A/S - Trading in Coloplast shares by board members, executives or…

Please see enclosed pdf. Attachment 08052025_trading_in_shares_GL
Nasdaq GlobeNewswire
08/05/2025

ACTO APPOINTS FORMER J&J PRESIDENT TO ITS BOARD OF DIRECTORS

Tierney most recently served as President of Johnson & Johnson Vision and brings a wealth of experience from senior global and regional leadership roles at J&J MedTech and Mentor Aesthetics Specialty Surgery. Her career spans high-impact commercial leadership positions at AstraZeneca, Endo Pharmaceuticals, and Centocor, where she successfully led large-scale teams across global, strategic, and in-line marketing and sales. With a proven track record overseeing commercial operations…
PR Newswire
08/05/2025

Exidavnemab phase 2a study expanded to include MSA patients

The study is conducted in Spain and Poland. In addition to the 24 participants with mild to moderate Parkinson's Disease, an additional 12 participants with MSA will be recruited. In addition to the primary endpoints of safety and tolerability, a broad range of biomarkers will be evaluated, in plasma, cerebrospinal fluid (CSF) and using digital measurements. The study is conducted inSpainandPoland. In addition to the 24 participants with mild to moderate Parkinson's Disease, an...
PR Newswire
08/05/2025

Safe Life Acquires HeartCert in the US, Continues to Build Out National Coverage…

"We are truly excited to welcome HeartCert as new members of the Safe Life team," says Jimmy Eriksson, CEO of Safe Life. "CPR and First Aid training are core pillars for us, and we are extremely happy to add a Midwest growth engine and to see our network and delivery coverage strengthen nationally. I look forward to what we are going to be able to achieve together. Life-saving technology within the reach of trained members of the community is how we help save more lives."…
PR Newswire
08/05/2025

NAVEE Partners with Dott to Launch Next-Gen V1 Pro Scooter, Redefining Urban…

The V1 Pro revolutionizes fleet management, setting an unprecedented industry benchmark with 110+ days of standby time—surpassing competitors by more than two months. With an ultra-low static power consumption (<0.4W), it significantly reduces maintenance costs and ensures continuous fleet readiness. Its rapid 5-hour charging capability and powerful 1150Wh battery deliver over 110km of range, maximizing fleet availability and minimizing downtime in busy urban areas. The V1 Pro…
PR Newswire
08/05/2025

RECORDATI: STRONG MOMENTUM OF THE GROUP CONTINUES INTO THE FIRST QUARTER OF 2025…

Consolidated net revenue of € 680.0 million in the first quarter of 2025, +11.9% or +7.2% on a like-for-like basis (3)and at constant exchange rates (CER)EBITDA (1)of € 270.2 million, +10.7%, margin on revenue of 39.7% Adjusted net income (2)of € 175.5 million, +7.2% Net income of € 125.0 million, +1.2%Free cash flow (4)of € 158.8 million, +€ 11.7millionvs prior yearNet debt (5)at € 2,020.8 million, just below 2.2x EBITDA...
Nasdaq GlobeNewswire
08/05/2025

Bulletin from Sobi's Annual General Meeting (AGM)

The AGM adopted the income statements and the balance sheets and approved the proposal to carry forward the retained profits. The AGM adopted the income statements and the balance sheets and approved the proposal to carry forward the retained profits. The Board members and the chief executive officer were discharged from liability for the financial year 2024. Election of Board of Directors, remuneration to the Directors, election of Auditor and remuneration to the Auditor The...
PR Newswire
08/05/2025

Colorcon and ASHA Cellulose Announce New Partnership to Support the Development…

Raju Shah, President for ASHA Cellulose, commented: "Asha Cellulose has been involved in manufacturing ASHACEL Ethyl Cellulose and ASHAKOTE Aqueous Ethyl Cellulose dispersion using in-house capabilities and a world-class infrastructure. With this partnership, we are confident that the unique combination of our polymer expertise and Colorcon's technical prowess and customer reach will help us serve our customers better." Raju Shah, President for ASHA Cellulose, commented: "Asha…
PR Newswire
08/05/2025

Contour Design Signs Agreement to Acquire Active Key Business from Cherry SE

"This acquisition is a pivotal moment for Contour Design, aligning perfectly with our mission to enhance health and safety at workplaces," said Erik Stannow, Chairman of the Board at Contour Design. "Active Key's deep expertise in hygienic input devices complements our ergonomic strengths, allowing us to meet the growing demands of health-conscious industries." "This acquisition is a pivotal moment for Contour Design, aligning perfectly with our mission to enhance health…
PR Newswire
08/05/2025

Nordic Bioscience announces PRO-C3 launched by Roche Diagnostics on cobas…

The nordicPRO-C3™ biomarker is already validated in Nordic Bioscience CAP-CLIA certified laboratory inDenmark. This demonstrates that Nordic Bioscience is dedicated to helping patients in a precision medicine driven approach, and our Platform provides the quality needed for regulatory approval. Nordic Bioscience's scientists have over that last 10 years published more than 250 scientific papers on PRO-C3 making us the leading place for research within PRO-C3 and fibrotic related...
PR Newswire
08/05/2025

iOnctura commences randomized Phase I/II study in non-small cell lung cancer

Anti-programmed death-ligand 1 (PD-L1) or anti-programmed cell death protein 1 (PD1) immunotherapy is a standard therapy for NSCLC patients with no actionable mutations in the first or second lines of therapy, with or without chemotherapy. However, treatment is often of limited duration as the cancer cells develop resistance to the treatment. Rebalancing the immune system via PI3Kδ inhibition is thought to re-invigorate anti-tumour immune cells and thus is a promising mechanism to overcome…
PR Newswire
08/05/2025

The Galien Foundation Announces 2025 Prix Galien UK Forum and Awards Ceremony in…

Celebrating excellence in life sciences, biotechnology, and pharmaceutical innovation, the 2025 event will bring together industry leaders, researchers, policymakers, and patient advocates to engage in meaningful dialogue on the future of health and medicine. The Forum, hosted at the Science Museum, will feature a full day of thought-provoking panels, followed by the prestigious Prix Galien UK Awards Ceremony at the Natural History Museum, featuring this year's illustrious keynote speaker…
PR Newswire
08/05/2025

EAACI Hong Kong Allergy School 2025: A Landmark in Global Allergy Education

Under the theme “East Meets West”, the 2025 edition of the Allergy School represents a bold step in fostering cross-continental collaboration in allergy and clinical immunology. By bringing together leading global experts, this flagship event aims to enrich knowledge exchange, advance clinical practices, and inspire innovative solutions to allergy care worldwide.Participants will benefit from a rich, interdisciplinary scientific programme, featuring renowned international faculty and...
Nasdaq GlobeNewswire
08/05/2025
Altri  Comunicati